C-reactive protein and colorectal adenoma in the CLUE II cohort

被引:0
|
作者
Konstantinos K. Tsilidis
Thomas P. Erlinger
Nader Rifai
Sandy Hoffman
Judy Hoffman-Bolton
Kathy J. Helzlsouer
Elizabeth A. Platz
机构
[1] Johns Hopkins Bloomberg School of Public Health,Department of Epidemiology
[2] University of Texas Medical Branch,Department of Internal Medicine
[3] Boston Children’s Hospital and Harvard Medical School,Department of Laboratory Medicine
[4] Johns Hopkins Bloomberg School of Public Health,George W. Comstock Center for Public Health Research and Prevention
[5] Mercy Medical Center,Prevention and Research Center, Weinberg Center for Women’s Health and Medicine
[6] Johns Hopkins Medical Institutions,The Sidney Kimmel Comprehensive Cancer Center
来源
Cancer Causes & Control | 2008年 / 19卷
关键词
C-reactive protein; Inflammation; Colorectal neoplasms; Risk;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:559 / 567
页数:8
相关论文
共 50 条
  • [1] C-reactive protein and colorectal adenoma in the CLUE II cohort
    Tsilidis, Konstantinos K.
    Erlinger, Thomas P.
    Rifai, Nader
    Hoffman, Sandy
    Hoffman-Bolton, Judy
    Helzlsouer, Kathy J.
    Platz, Elizabeth A.
    CANCER CAUSES & CONTROL, 2008, 19 (06) : 559 - 567
  • [2] Metabolic syndrome components and colorectal adenoma in the CLUE II cohort
    Tsilidis, Konstantinos K.
    Brancati, Frederick L.
    Pollak, Michael N.
    Rifai, Nader
    Clipp, Sandra L.
    Hoffman-Bolton, Judith
    Helzlsouer, Kathy J.
    Platz, Elizabeth A.
    CANCER CAUSES & CONTROL, 2010, 21 (01) : 1 - 10
  • [3] A Prospective Evaluation of C-reactive Protein Levels and Colorectal Adenoma Development
    Gunter, Marc J.
    Cross, Amanda J.
    Huang, Wen-Yi
    Stanczyk, Frank Z.
    Purdue, Mark
    Xue, Xiaonan
    Schoen, Robert
    Limburg, Paul J.
    Schatzkin, Arthur
    Sinha, Rashmi
    Hayes, Richard B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (03) : 537 - 544
  • [4] Baseline serum C-reactive protein and death from colorectal cancer in the NHANES III cohort
    Swede, Helen
    Hajduk, Alexandra M.
    Sharma, Jyoti
    Rawal, Shristi
    Rasool, Homaira
    Vella, Anthony T.
    Tobet, Rebecca E.
    Stevens, Richard G.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (08) : 1862 - 1870
  • [5] PentraSorb C-Reactive Protein: Characterization of the Selective C-Reactive Protein Adsorber Resin
    Mattecka, Stephan
    Brunner, Patrizia
    Haehnel, Britta
    Kunze, Rudolf
    Vogt, Birgit
    Sheriff, Ahmed
    THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (05) : 474 - 481
  • [6] Elevated maternal C-reactive protein and autism in a national birth cohort
    Brown, A. S.
    Sourander, A.
    Hinkka-Yli-Salomaki, S.
    McKeague, I. W.
    Sundvall, J.
    Surcel, H-M
    MOLECULAR PSYCHIATRY, 2014, 19 (02) : 259 - 264
  • [7] C-reactive protein and hypertension
    Hage, F. G.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (07) : 410 - 415
  • [8] C-reactive protein and colorectal cancer risk: A systematic review of prospective studies
    Tsilidis, Konstantinos K.
    Branchini, Casey
    Guallar, Eliseo
    Helzlsouer, Kathy J.
    Erlinger, Thomas P.
    Platz, Elizabeth A.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1133 - 1140
  • [9] Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
    Toriola, Adetunji T.
    Ulrich, Cornelia M.
    FUTURE ONCOLOGY, 2011, 7 (10) : 1125 - 1128
  • [10] Prognostic Value of C-Reactive Protein, Glasgow Prognostic Score, and C-Reactive Protein-to-Albumin Ratio in Colorectal Cancer
    Zhou, Jiahui
    Wei, Wene
    Hou, Hu
    Ning, Shufang
    Li, Jilin
    Huang, Baoyue
    Liu, Kaisheng
    Zhang, Litu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9